GL1X · GenesisL1 explorer

MolNFT v1 · #71180 · protein

CD11A I-domain complexed with 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5- dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7- TRIAZASPIRO[4.4]NON-7-yl) nicotinic acid

3M6F · Integrin alpha-L: “CD11A I-domain complexed with 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5- dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7…”. X-ray diffraction, 2 ligands (BJZ, NO3), 1 pocket (best druggability 0.65). MolNFT v1 #71180 on…

PDB
3M6F
Type
protein
Length
180 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrin alpha-L
UniProt
P20701
Ligands
BJZ, NO3
Pockets
1 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegrin alpha-Lprotein18041% helix, 23% strandP20701

Ligands and binding sites

  • BJZ · 6-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl]pyridine-3-carboxylic acid · ligand · chains A
  • NO3 · Nitrate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12260.650.8223BJZ

Compared structures

  • 3M6F · CD11A I-domain complexed with 6-((5S,9R)-9-(4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1-METHYL… · the same entry in another collection · chain A against A, TM-score 1.00
  • P20701 · AlphaFold monomer V2.0 prediction for integrin alpha-L (P20701) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.